Quintiles Completes New Investor Partnership

PRLog (Press Release) – Jan 28, 2008 – Quintiles Transnational (Research Triangle Park, North Carolina) has completed a new investor partnership in which CEO Dennis Gillings and private investment firms Bain Capital and TPG Capital have become the lead investors. 3i has also made a significant investment and Temasek Holdings remains an investor. As part of the transaction, former lead investor One Equity Partners (the private equity arm of JPMorgan Chase) has sold its stake in Quintiles to the new partnership.

Terms of the transaction were not disclosed. The company incurred no new debt as a result of the deal.

Bain Capital (Boston, Massachusetts) has some $65,000 million in assets under management. Its other healthcare investments include HCA, Warner Chilcott, CRC Health Group, Stericycle, M|C Communications, Wesley Jessen and Physio Control. TPG Capital is the global buyout group of private investment firm TPG, which has around $35,000 million of assets under management. 3i has assets of $16,000 million across Europe, North America and Asia. Temasek Holdings (Singapore) manages a diversified S$164,000 million (US$108,000 million) portfolio, primarily in Asia. Article by www.jobs4dd.com, a specialist online recruitment service for the clinical trial and drug development sectors. Latest news and jobs in the industry are listed on a daily basis.